Skip to content
WeighLab

Emerge Weight Loss vs Midi Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Emerge Weight Loss

Provider comparison

Shoppers who specifically want tirzepatide with per-dose-tier pricing shown up front, not semaglutide.

Semaglutide / month
Not disclosed
Tirzepatide / month
$224 per 4 weeks2.5 mg starting dose, compounded
Index 57/100 · Grade CChecked October 2026

Midi Health

Provider comparison

Women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.

Semaglutide / month
$166/mo0.5 mg dose, plus a separate fee, compounded
Tirzepatide / month
$210/mo2.5 mg dose, plus a separate fee, compounded
Index 57/100 · Grade CChecked August 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 57/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Emerge Weight Loss
Coverage not published
Midi Health
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Emerge Weight Loss

Midi Health

Semaglutide / month
Emerge Weight Loss: Not disclosed
Midi Health: $166/mo0.5 mg dose, plus a separate fee, compounded
Tirzepatide / month
Emerge Weight Loss: $224 per 4 weeks2.5 mg starting dose, compounded
Midi Health: $210/mo2.5 mg dose, plus a separate fee, compounded
Semaglutide / year (modeled)
Emerge Weight Loss: —
Midi Health: $1,992
Tirzepatide / year (modeled)
Emerge Weight Loss: $2,91213 charges
Midi Health: $2,520
State availability
Emerge Weight Loss: Coverage not published
Midi Health: All 50 states
Oral / sublingual option listed
Emerge Weight Loss: Yes
Midi Health: Not listed
Brand-name access listed
Emerge Weight Loss: Not confirmed
Midi Health: Not confirmed
Provider facts checked
Emerge Weight Loss: October 2026
Midi Health: August 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Emerge Weight Loss

Shoppers who specifically want tirzepatide with per-dose-tier pricing shown up front, not semaglutide.

Reasons to consider it

  • Publishes a price for every dose, $224 to $289 per four weeks across six strengths, rather than a single 'starting at' figure
  • No signup fee and no separate doctor fee — the FAQ states syringes, overnight shipping and medical oversight are bundled into the quoted price
  • No minimum commitment; cancel anytime with only a $10 processing fee if an order hasn't shipped yet

What to weigh up

  • No semaglutide product at all — Emerge is tirzepatide-only, so it's not an option for patients who specifically want or are already on semaglutide
  • The 'Maintenance Plans from $49 per 4 weeks' line is misleading on its own — refills actually cost $99/vial, so $49 is a floor, not the real recurring price
  • The two highest dose tiers (12.5mg and 15mg, $279-$289) are restricted to existing patients only, so new patients can't see or lock in pricing for where they may eventually titrate

Midi Health

Women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.

Reasons to consider it

  • No membership fee — the site states outright 'You only pay for your care and your medications'
  • Medication price already includes shipping and supplies, so the listed number is closer to the true out-of-pocket cost than sites that add fees later
  • Dose-tiered pricing is published transparently: compounded semaglutide $165.90-$355.00/mo, compounded tirzepatide $210.00-$434.00/mo depending on dose

What to weigh up

  • The advertised 'Weekly doses start at $34' teaser on the weight-management overview page refers to microdosing, not the standard program — the real 4-week program cost starts at $165.90/mo, over 4x the teaser figure
  • Weight care is not Midi's core identity — it's layered onto a menopause/HRT platform, so patients whose only need is GLP-1 may find a weight-loss-only provider more streamlined
  • No flat cash price is published for brand-name Wegovy/Zepbound — those go through the patient's own pharmacy/insurance, so actual cost is unknown until benefits are checked

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Emerge Weight LossMidi Health
Normalized Cost/Month
Emerge Weight Loss:
47/100
Midi Health:
49/100
Price Transparency
Emerge Weight Loss:
78/100
Midi Health:
20/100
Nationwide Access
Emerge Weight Loss:
24/100
Midi Health:
86/100
Formulation Options
Emerge Weight Loss:
64/100
Midi Health:
66/100
Clinical Oversight
Emerge Weight Loss:
85/100
Midi Health:
77/100
Contract Flexibility
Emerge Weight Loss:
55/100
Midi Health:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.